Signet Healthcare Partners

Juno Pharmaceuticals produces and distributes amoxicillin, hydrochloride syringes, hydromorphone solutions, phentermine tablets & capsules.

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes of administration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.

GI Supply was founded nearly 30 years ago by Dr. Frank Jackson, a gastroenterologist and entrepreneur, to help solve many of the clinical challenges he faced in daily practice. The products he built in partnership with other GI physicians and nurses help improve physician efficiency and patient satisfaction. Today, GI Supply products are used around the world daily by gastroenterologists and colorectal surgeons in more than 40 countries.

SMART Medical Systems Ltd, provides enabling medical devices that revolutionize the concept and practice of gastrointestinal (GI) endoscopy. The company focuses on innovative devices with the vision of providing widespread, cost-effective solutions, enabling superior endoscopy for the benefit of both doctors and patients. SMART is lead by a highly dedicated team of professionals and has established close relations with outsource manufacturing facilitiies for the production of its products. SMART is backed by high level private investors. SMART’s proprietary balloon technology is implemented in its various products. SMART’s flagship product – the G-EYE™ endoscope is a unique and innovative device enabling the increasing of polyp detection rate in the day to day colonoscopy in a simple and intuitive manner. By implementing its balloon technology into the G-EYE™ system, the endoscope enables Controlled Withdrawal™ of the endoscope during colonoscopy, thus improving visibility of the colon and making therapy and intervention much easier and faster. The G-EYE™ together with SMART’s single balloon disposables can also act as an optimized two-balloon system for deep small bowel enteroscopy and double balloon colonoscopy. SMART is ISO 13485:2003 certified by the European regulatory authorities, and maintains a comprehensive quality assurance approach to ensure the quality of its products

Leading Pharma is a privately owned generic pharmaceutical company that purchases, licenses, develops, manufactures and distributes high-quality, safe and effective products to drugstore chains, distributors, wholesalers, mass merchandisers, government agencies and managed care accounts in the U.S. Their products are available in various dosage forms across many therapeutic areas under the Leading label.At Leading, their mission is simple: to provide quality, affordable, safe and effective pharmaceutical products to the people who need them. Their team is dedicated to providing their customers with outstanding customer service, innovative marketing strategies, quality manufacturing, efficient distribution and stringent regulatory compliance to ensure safety every step of the way.

TELA Bio is a life science company that specializes in soft tissue reconstruction. The company aims to commercialize a portfolio of products that are purposefully designed to address a range of unmet needs in soft tissue repair.

Pharmaceutics International operates as a science-driven contract development and manufacturing company. It offers scientific insight and depth of product knowledge to supply high-quality dosage forms that enhance the lives of patients.

leon nanodrugs a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical stage formulations for their clients NCEs or branded established drugs. leon-nanodrugs offers access to the next generation of nano-formulated drugs with meaningful differentiation and added patient benefits. They specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles.

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships. It is licensed to do business in the United States and is accomplished in the areas of product development, regulatory affairs, quality management, sales and distribution, and supply chain management. Today, Bionpharma is one of the largest suppliers of soft gel capsules in the US market with a strong presence in both the prescription and over-the-counter markets. Launched in 2014, BionPharma was founded by a team of executives and professionals with years of cumulative experience in the generics industry. It is based in Princeton, New Jersey, and with offices in Raleigh, North Carolina.

KEW Group is a personalized oncology management company that provides DNA based genomic testing and interpretation services. It will deploy proprietary oncology therapeutic pathways and personalized medicine tools, including genetic and genomic information, in the community oncology care setting, enabling the highest quality clinical care, efficiently delivered. It was founded in 2009 and is based in Cambridge, Massachusetts.

Sancilio & Company develops, manufactures, and distributes biopharmaceutical products in the United States and internationally. Its cardiovascular health products include OCEAN BLUE PROFESSIONAL OMEGA-3 2100, which is made from fish oils to decrease the risk of arrhythmias. The company also provides dental health products, including LUDENT SODIUM FLUORIDE CHEWABLE TABLETS that provide fluoride to the children; MVC MULTIVITAMIN WITH FLUORIDE CHEWABLE TABLETS, which contain vitamins and minerals; and sodium fluoride drops. In addition, it offers women’s health products, which include Mylk, a multivitamin/mineral/essential fatty acid softgel; and Caltranate, a blend of calcium formulated to control the release of calcium. Further, Sancilio & Company provides pharmaceutical services, such as analytical chemistry, dissolution testing, formulation development, de-formulation studies, HPLC, GC, GC/MS, and LC/MS support, raw material sourcing, contract tablet, capsule, and soft gel production, small-batch contract manufacturing, bottling/packaging, liquid filling of oral liquids, validation, product sales, and distribution and logistical support services. The company was founded in 2004 and is based in Stuart, Florida with additional offices in Ohio and New Jersey.

Fluxion Biosciences was formed in 2005 to address critical needs for cellular analysis tools in the pharmaceutical, biotech and research industries. The company has developed a proprietary microfluidic platform which enables precise cellular manipulation, rapid low-volume compound addition, environmental control and software-based data acquisition.

Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.

Headquartered in San Diego, California, Pfēnex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfēnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfēnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.

SpePharm is a European specialty pharmaceutical company dedicated to acquiring, registering and marketing high medical value medicines throughout Europe, essentially for the hospital market. The SpePharm management team has a wealth of global experience within the pharmaceutical industry. In particular, the team has a well-established and in-depth knowledge of the European regulatory system, the hospital market, and niche and orphan products, with novel approaches and proven successes.

PEAK Surgical is a medical device company that is committed to providing physicians with surgical tools that have the precision of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral damage – a revolutionary benefit that fills a critical market gap. The PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States and for use in general surgery in the EU. PEAK Surgical is headquartered in Palo Alto, California.

DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.

Alpex Pharma is a pharmaceutical company active in Research & Development and Production of ODT (Orally Dispersible Tablet) called also "fast melt" and effervescent tablets. Alpex Pharma has developed a unique proprietary covering ODT technology. The high production capacity and advanced R&D technologies makes Alpex Pharma to be one of the most important company of the world in the field of fast melt and effervescent tablets. The company has a state-of-the-art manufacturing and R&D facilities of some 7000 square meters, with separate pharmaceutical and nutritional plant GMP compliant.

Atlantis has designed a software system known as the Virtual Abutment Design (VAD) system. VAD allows their technicians to design abutments with a certainty and precision previously unknown to implant dentistry. The following is an overview of the Atlantis VAD and titanium machining process. The same process is followed by their technicians for single and multiple unit cases.

Cedarburg Hauser Pharmaceuticals is an experienced contract development and manufacturing organization (CDMO) for active pharmaceutical ingredients (APIs) and intermediates We offer multiple sites for non-GMP R&D projects, GMP kilo labs for early phase projects and GMP plant capacity for late stage and commercial APIs. We apply our drug development experience and expertise to help our clients successfully advance their drug candidate from early preclinical evaluations through clinical trials and eventually to market.